A New Wave for Hereditary Breast and Ovarian Cancer

Explore a comprehensive webinar on the latest developments in hereditary breast and ovarian cancer research. Delve into a selective literature review of recent papers, presented by Michelle Jackson, a product manager at Ambry Genetics. Gain insights into various aspects of hereditary cancers, including risk factors, cancer spectrum, and genotype-phenotype correlations. Examine data from studies on PAL2, RAD51, and NF1 genes, as well as information on triple-negative breast cancer and mutation carriers. Learn about the impact of ethnicity, risk modifiers, and family history on cancer susceptibility. Discover Ambry Genetics' panels and their approach to updating genetic testing offerings. Engage with discussions on male breast cancer, internal data studies, and upcoming events in the field. Conclude with a Q&A session addressing panel updates, gene inclusion requests, and specific mutation inquiries.

Introduction
Outline
Ambry Genetics
Other Panels
Risk
Cancer Spectrum
Poster
New England Journal of Medicine
Family History Groups
PAL2 Data
RAD51 Data
NF1 Data
TN Mutation Carriers
HBOC Heterogeneity
genotypephenotype correlations and mutation carriers
risk modifiers
ethnicity data
triple negative breast cancer
study summary
mutation frequencies
male breast cancer
internal data
studies
study
upcoming events
surf on comm
Bethany Hamilton
Ambry Genetics Executive Director
How to sign up
List of competitors
Surfing
Registration
Foundation Registration
Foundation Lottery
Breast Cancer Awareness Month
Join the battle
Questions
How often do you update your panels
If there are genes that you want to see on your panels
Will there be any followup additional info for the NSH2 mutation
Any other questions